Yiming Su, Ru Chen, Rong Liu, Jianhui Chen, Shaoxing Zhu. "Selective bladder preservation after neoadjuvant zanidatamab combined with tislelizumab and chemotherapy in patients with HER2-positive muscle-invasive bladder cancer (HARBOR): A multicenter study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.tps887